How Fig Polyphenols Affect Blood Sugar and Insulin Levels After Eating in Adults at Risk for Diabetes
FG
Acute Pharmacokinetics of Fig Polyphenols and Postprandial Glucose-Insulin Responses in Pre-diabetic Adults.
1 other identifier
interventional
5
1 country
1
Brief Summary
The study purpose is to understand how the body absorbs and metabolizes nutrient-like components in dried figs called polyphenols over 24 hours. The study is also done to know if polyphenols will help a hormone called insulin work better in the body, so to look further into the possibility of figs being a functional food for the pre-diabetic population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 12, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 22, 2026
CompletedFirst Submitted
Initial submission to the registry
May 29, 2026
CompletedFirst Posted
Study publicly available on registry
June 4, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2027
ExpectedJune 4, 2026
May 1, 2026
2 months
May 29, 2026
May 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Blood glucose levels
Blood glucose levels with and without dried figs.
From enrollment to the end of treatment at 2 weeks
Blood Insulin levels
Blood insulin levels with and without dried figs.
From enrollment to the end of treatment at 2 weeks
Secondary Outcomes (1)
Polyphenols
From enrollment to the end of treatment at 2 weeks
Study Arms (2)
Fig Breakfast
EXPERIMENTALStandardized breakfast with 40g of figs
Control breakfast
PLACEBO COMPARATORStandardized breakfast with calorie matched control ingredients
Interventions
Eligibility Criteria
You may qualify if:
- Be between 30-50 years old.
- Have a BMI of 25-35 kg/m².
- Have fasting blood glucose between 100-125 mg/dL or Glycated hemoglobin (HbA1c) between 5.7-6.4%.
- Be non-smokers for at least 12 months.
- Be generally healthy, with no major organ-related diseases.
- Not take medications or supplements that could interfere with the study.
- Be able to follow study procedures, including dietary restrictions and scheduled visits
You may not qualify if:
- Smoker
- Vegetarian
- Taking over the counter supplements (e.g. fiber supplements, probiotics and/or prebiotics, antioxidants, anti-inflammation) and/or taking prescription medications that may interfere with study procedures or endpoints (e.g. Gastrointestinal medications, antibiotics) within the last 30 days
- Have cancer other than non-melanoma skin cancer in previous 5 years
- Taking unstable dose of hormonal contraceptive and/or stable dose less than 6 months
- Planning to become pregnant
- Pregnant and/or breast-feeding
- Excessive exercisers or trained athletes
- Excessive coffee/tea drinker
- Donated blood within last 3 months
- Have allergies/intolerances to foods consumed in the study
- Regular consumption of dried fruits exceeds \> 2 servings per day
- Actively losing weight/ trying to lose weight (unstable body weight fluctuations of \> 5 lbs in 3 months)
- Addicted to drugs or alcohol or have significant psychiatric or neurological disturbances
- Past smokers may be allowed in the study if stopped \>2 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Illinois Tech
Chicago, Illinois, 60616, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amandeep Sandhu, PHD
Food Sci and Nut Programs
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 29, 2026
First Posted
June 4, 2026
Study Start
March 12, 2026
Primary Completion
May 22, 2026
Study Completion (Estimated)
May 15, 2027
Last Updated
June 4, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
Pilot study